These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 19386478

  • 1. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
    Prasad E, Viswanathan PN, Rangad VF, Pavamani S, Ram TS.
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478
    [Abstract] [Full Text] [Related]

  • 2. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ, Liu SP, Wang XE.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):821-7. PubMed ID: 20207507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E, La Face B, Bianchi E, Cagna E, Sartori E.
    Radiol Med; 1996 May 01; 91(5):628-34. PubMed ID: 8693131
    [Abstract] [Full Text] [Related]

  • 9. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC, Ho ES, Jan JS, Yang CH, Liu FS.
    Gynecol Oncol; 1996 Apr 01; 61(1):101-8. PubMed ID: 8626094
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study.
    Vrdoljak E, Prskalo T, Omrcen T, Situm K, Boraska T, Frleta Ilić N, Janković S, Hamm W.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):824-9. PubMed ID: 15708262
    [Abstract] [Full Text] [Related]

  • 12. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K, Jassem J.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):814-21. PubMed ID: 15465198
    [Abstract] [Full Text] [Related]

  • 13. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY, Wu HG, Kim K, Ha SW, Kim JS, Kim IA, Lee HP.
    Gynecol Oncol; 2007 Jan 01; 104(1):95-9. PubMed ID: 16996117
    [Abstract] [Full Text] [Related]

  • 14. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E, Omrcen T, Novaković ZS, Jelavić TB, Prskalo T, Hrepić D, Hamm W.
    Gynecol Oncol; 2006 Nov 01; 103(2):494-9. PubMed ID: 16814371
    [Abstract] [Full Text] [Related]

  • 15. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy.
    Morris M, Eifel PJ, Burke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DM.
    Gynecol Oncol; 1995 Apr 01; 57(1):72-8. PubMed ID: 7705704
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ, Rotmensch J, Waggoner SE, Yamada SD, Fleming GF.
    Gynecol Oncol; 2004 Mar 01; 92(3):801-5. PubMed ID: 14984944
    [Abstract] [Full Text] [Related]

  • 17. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Yuxing Y, Devi CR, Bustam AZ, Calaguas MJ, de los Reyes RH, Cho CK, Dung TA, Supriana N, Mizuno H, Nakano T, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):751-7. PubMed ID: 19836154
    [Abstract] [Full Text] [Related]

  • 18. Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study.
    Viegas CM, Araujo CM, Dantas MA, Froimtchuk M, Oliveira JA, Marchiori E, Souhami L.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1154-9. PubMed ID: 15519787
    [Abstract] [Full Text] [Related]

  • 19. Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study.
    Addeo D, Blank S, Muggia F, Formenti S.
    Anticancer Res; 2008 Nov 15; 28(5B):3143-6. PubMed ID: 19031972
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.